Back
ClearShares Ultra-Short Maturity ETF Vs. Avidity Biosciences, Inc. Industry Stock Comparison
Buy
56
OPER
ClearShares Ultra-Short Maturity ETF
Last Price:
$100.17
Seasonality Move:
-0.09%
Buy
64
RNA
Avidity Biosciences, Inc.
Last Price:
$72.32
Seasonality Move:
29.53%
Buy
56
ClearShares Ultra-Short Maturity ETF (OPER)
is a Buy
Is ClearShares Ultra-Short Maturity ETF a Buy, Sell or Hold?
-
The current ClearShares Ultra-Short Maturity ETF [OPER] share price is $100.23. The Score for OPER is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
OPER is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
64
Avidity Biosciences, Inc. (RNA)
is a Buy
Is Avidity Biosciences, Inc. a Buy, Sell or Hold?
-
The current Avidity Biosciences, Inc. [RNA] share price is $72.34. The Score for RNA is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
RNA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
OPER Stock Price Chart
What is ClearShares Ultra-Short Maturity ETF's stock price today?
-
The ClearShares Ultra-Short Maturity ETF share price today is $100.23The current trend is moderately bullish and OPER is experiencing slight selling pressure.
RNA Stock Price Chart
What is Avidity Biosciences, Inc.'s stock price today?
-
The Avidity Biosciences, Inc. share price today is $72.34Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing slight buying pressure.
OPER Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 60.69 | Buy |
| Chaikin Money Flow: | -433 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (100.06 - 100.24) | Buy |
| Bollinger Bands (100): | (100.1 - 100.34) | Buy |
RNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 13.57 | Buy |
| Relative Strength Index (14 RSI): | 77.3 | Buy |
| Chaikin Money Flow: | 547948 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (70.95 - 71.89) | Buy |
| Bollinger Bands (100): | (42.54 - 68.1) | Buy |
OPER Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 100.18 | Buy |
| 20-day SMA: | 100.14 | Buy |
| 50-day SMA: | 100.17 | Buy |
| 200-day SMA: | 100.25 | Sell |
| 8-day EMA: | 100.18 | Buy |
| 20-day EMA: | 100.15 | Buy |
| 50-day EMA: | 98.41 | Buy |
| 200-day EMA: | 63.71 | Buy |
RNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 71.87 | Buy |
| 20-day SMA: | 71.59 | Buy |
| 50-day SMA: | 66.05 | Buy |
| 200-day SMA: | 42.99 | Buy |
| 8-day EMA: | 38.2 | Buy |
| 20-day EMA: | 18.71 | Buy |
| 50-day EMA: | 8.16 | Buy |
| 200-day EMA: | 2.13 | Buy |
ClearShares Ultra-Short Maturity ETF Earnings Growth & OPER Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Avidity Biosciences, Inc. Earnings Growth & RNA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.63 per share, and a decrease next year of $0.40 per share.
ClearShares Ultra-Short Maturity ETF Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Avidity Biosciences, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||